Haverford Trust CO Organon & Co. Transaction History

Haverford Trust CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$17.45 - $21.96 $173,679 - $218,567	9,953 New	9,953 $206,000
Q3 2021 Nov 12, 2021	SELL	$28.63 - $35.64 $285,068 - $354,867	-9,957 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$28.45 - $38.0 $274,713 - $366,928	9,656 Added 3207.97%	9,957 $301,000
Q2 2021 Aug 16, 2021	BUY	$28.45 - $38.0 $8,563 - $11,438	301 New	301 $301,000

794

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.71B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Haverford Trust CO, based on Form 13F filings with the SEC.

Stay updated on Haverford Trust CO with notifications on news.